Overview of Two Monographs on Pain Management
Despite a growing array of treatment options, pain is still poorly managed and undertreated in the United States. In 2001, the Joint Commission on Accreditation of Healthcare Organizations and the National Pharmaceutical Council began a collaborative effort to facilitate improvements in pain management. To date, this effort has produced a set of monographs intended for those involved in pain management activities, including clinicians, quality management professionals, and others involved in pain management performance, assessment, improvement, education, and policy making. These materials give audiences concrete and relevant information about how care practices can be improved, and patient suffering alleviated.
CER Tweets of the Week (June 3-7, 2013)
The Patient-Centered Outcomes Research Institute (PCORI) generated buzz on Twitter this week with the announcement of the winners of the PCORI...
E.V.I.dently May 2013
Message From NPCThe Role of Pharmaceuticals in Health Insurance ExchangesOne of the most pressing issues in the implementation of the Affordable Care...Test Blog Post
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce luctus arcu sed erat malesuada tincidunt. Ut commodo ante et tortor egestas nec...The Role of Pharmaceuticals in Health Insurance Exchanges
As part of the implementation of the Affordable Care Act, a series of state health insurance exchanges are being established across the United States...
NPC Welcomes Dr. Bryan Luce as PCORI Chief Science Officer
WASHINGTON, DC (April 24, 2013) The National Pharmaceutical Council today welcomed the news that the Patient-Centered Outcomes Research Institute (...Leading Researchers Outline Principles for Conduct of Comparative Effectiveness Research
WASHINGTON, DC (September 11, 2012)—A new set of principles developed by a group of leading researchers could help to ensure more consistency in how...Study Quantifies Impact of Pharmaceuticals on Enhanced Productivity
(WASHINGTON, DC, August 1, 2012)–The costs to employers of chronic health conditions on employee productivity are well documented, but few studies...Pharmaceuticals Play Key Role in Achieving ACO Quality, Cost Goals
WASHINGTON, DC, July 18, 2012–As health care providers set up accountable care organizations (ACOs) and other value-based care programs,...
Leveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?
A growing chorus of voices is publicly sharing data on the effectiveness of treatment options, but one viewpoint has long been shut out of key areas...Framework Helps ACOs Leverage Pharmaceuticals to Realize Quality, Cost Goals
Medications are more than an item on the balance sheet for health care providers. Pharmaceuticals offer a route to manage costs while achieving...National Pharmaceutical Council Prepared Commentary Before the Patient-Centered Outcomes Research Institute
Thank you for the opportunity to comment. I have enjoyed the opportunity to witness first-hand the progress, careful thought and deliberation, and...Comparative Effectiveness Research and the Changing Health Care Landscape
This content appeared in the January 2, 2012 print edition of Chain Drug Review. In the span of just one year, the health care landscape has...
Patients, Research and Access to Health Care
Myrl Weinberg, FASAE, CAE, president of the National Health Council, says that it's important to for individuals, especially those with chronic...PCORI Outlines Efforts to Engage Patients
Dr. Rachael Fleurence, Scientist,Patient-Centered Outcomes Research Institute, outlines the many ways heragency is engaging patients and other...Challenges in Communicating Comparative Effectiveness Research
Dr. Robert Dubois, Chief Science Officer, National Pharmaceutical Council (NPC), describes the issue of "asymmetry" in the comparative effectiveness...UPenn's Dr. Caplan on Communicating CER to Patients
Univ. of Pennsylvania Director of the Center for Bioethics Dr. Art Caplan outlines an ethical framework for communicating comparative effectiveness...CER Tweets of the Week (June 3-7, 2013)
The Patient-Centered Outcomes Research Institute (PCORI) generated buzz on Twitter this week with the announcement of the winners of the PCORI...Test Blog Post
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce luctus arcu sed erat malesuada tincidunt. Ut commodo ante et tortor egestas nec...The Role of Pharmaceuticals in Health Insurance Exchanges
As part of the implementation of the Affordable Care Act, a series of state health insurance exchanges are being established across the United States...A Look at Rx Coverage and Cost in the New Health Insurance Exchanges
National Pharmaceutical Chief Science Officer Dr. Robert Dubois will lead a panel discussion, "Capturing the Value of Pharmaceuticals--A Look at Rx...Research
Component Management Fails to Save Health Care System Costs: The Case of Restrictive Formularies
The general failure of formularies and other limitat
Pain: Current Understanding of Assessment, Management, and Treatments
Pain is the most common reason individuals seek heal
Pharmaceuticals for Elders: Why Innovation Matters
The current policy debate over drug-benefit reform a
- 1 of 38
- >
Commentary & Testimony
Leveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?
Framework Helps ACOs Leverage Pharmaceuticals to Realize Quality, Cost Goals
National Pharmaceutical Council Prepared Commentary Before the Patient-Centered Outcomes Research Institute
Comparative Effectiveness Research and the Changing Health Care Landscape
CER: Who Can Say What, and When Can They Say It?